Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

5.900 +0.180 (+3.15%)

Streaming Delayed Price Updated: 10:41 AM EST, Dec 11, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	44,191
Open	5.420
Bid (Size)	5.790 (100)
Ask (Size)	5.920 (100)
Prev. Close	5.720
Today's Range	4.890 - 5.920
52wk Range	1.305 - 9.770
Shares Outstanding	20,161,073
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗

November 29, 2025

Here's why a fast-rising pharmaceutical trimmed—and not abandoned—by a specialist fund signals ongoing conviction in the stock.

Via The Motley Fool

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the company’s clinical-stage future.

Via The Motley Fool

Performance

YTD	+19.7%	+19.7%
1 Month	+41.8%	+41.8%
3 Month	+111.5%	+111.5%
6 Month	+257.6%	+257.6%
1 Year	-28.9%	-28.9%

More News

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗

November 18, 2025

Via The Motley Fool

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 14, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights

November 06, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

3 Healthcare Companies Insiders Are Buying ↗

October 14, 2025

Via MarketBeat

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

October 01, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 10, 2025

Via Benzinga

Wednesday's after hours session: top gainers and losers ↗

September 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders

September 10, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

Camp4 Reports Q2 Revenue Beats Estimates ↗

August 14, 2025

Via The Motley Fool

CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights

August 14, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 28, 2025

Via Benzinga

Sequans Appoints Jason W. Cohenour to Board of Directors

June 30, 2025

Via Newsfile

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 11, 2025

Via Benzinga

This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

May 27, 2025

Via Benzinga

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American

May 16, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights

May 13, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 06, 2025

Via Benzinga

Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket ↗

May 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 02, 2025

Via Benzinga

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

April 28, 2025

From CAMP4 Therapeutics

Via GlobeNewswire

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 ↗

April 10, 2025

Via Benzinga

Frequently Asked Questions

Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?

Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.

What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?

CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?

The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market

What is the current price of CAMP4 Therapeutics Corporation - Common Stock?

The current price of CAMP4 Therapeutics Corporation - Common Stock is 5.900

When was CAMP4 Therapeutics Corporation - Common Stock last traded?

The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 12/11/25 10:41 AM ET

What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?

The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 118.95M

How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?

CAMP4 Therapeutics Corporation - Common Stock has 119M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.